Skip to main content
Log in

Isoderivative of deleted chromosome 20 in primary myelofibrosis (PMF) characterized by molecular cytogenetics and array CGH

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. GFCH (2004) Recommandations pour la prise en charge cytogénétique des syndromes myéloprolifératifs autres que la leucémie myéloïde chronique (LMC) établies par le Groupe Français de Cytogénétique Hématologique (GFCH). Pathol Biol 52:241–244. doi:10.1016/j.patbio.2004.04.003

    Article  Google Scholar 

  2. Li T, Xue Y, Wu Y, Pan J (2004) Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-). Br J Haematol 125:337–342. doi:10.1111/j.1365-2141.2004.04921.x

    Article  PubMed  Google Scholar 

  3. Saunders K, Czepulkowski B, Sivalingam R, Hayes JPLA, Aldouri M, Sekhar M, Cummins M, Ho A, Mufti GJ (2005) Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes. Cancer Genet Cytogenet 156:154–157. doi:10.1016/j.cancergencyto.2004.03.018

    Article  PubMed  CAS  Google Scholar 

  4. Lim TH, Lim AS, Tien SL (2006) A novel isoderivative chromosome 20 in a patient with chronic myelomonocytic leukemia. Cancer Genet Cytogenet 170:80–82. doi:10.1016/j.cancergencyto.2006.04.005

    Article  PubMed  CAS  Google Scholar 

  5. Shetty S, Roland B (2008) Isoderivative chromosome 20 in bone marrow: three new cases. Cancer Genet Cytogenet 184:72–73. doi:10.1016/j.cancergencyto.2008.03.003

    Article  PubMed  CAS  Google Scholar 

  6. Douet-Guilbert N, Lai JL, Basinko A, Gueganic N, Andrieux J, Pollet B, Plantier I, Delattre C, Crepin O, Corm S, Le Bris MJ, Morel F, De Braekeleer M (2008) Fluorescence in situ hybridization characterization of ider(20q) in myelodysplastic syndrome. Br J Haematol 143:716–720. doi:10.1111/j.1365-2141.2008.07436.x

    Article  PubMed  CAS  Google Scholar 

  7. Reilly JT, Snowden JA, Spearing RL, Fitzgerald PM, Jones N, Watmore A, Potter A (1997) Cytogenetic abnormalities and prognostic significance in idiopathic myelofibrosis: a study of 106 cases. Br J Haematol 98:96–102. doi:10.1046/j.1365-2141.1997.1722990.x

    Article  PubMed  CAS  Google Scholar 

  8. Douet-Guilbert N, Basinko A, Morel F, Le Bris MJ, Ugo V, Morice P, Berthou C, De Braekeleer M (2008) Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions. Ann Hematol 87:537–544. doi:10.1007/s00277-008-0462-3

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. De Braekeleer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Douet-Guilbert, N., Andrieux, J., Laï, J.L. et al. Isoderivative of deleted chromosome 20 in primary myelofibrosis (PMF) characterized by molecular cytogenetics and array CGH. Ann Hematol 88, 1157–1159 (2009). https://doi.org/10.1007/s00277-009-0753-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-009-0753-3

Keywords

Navigation